Justin M. Barnes
Assistant Chief Resident (PGY-4), Radiation Oncology
Washington University School of Medicine in St. Louis
Justin Barnes is a radiation oncologist-in-training at Washington University School of Medicine in St. Louis and Barnes Jewish Hospital, where he currently serves as Assistant Chief Resident. He enjoys getting to know and working with patients with any type of cancer and their families. His research interests include the impacts of social and public policies on cancer outcomes, particularly insurance-related policies for nonelderly adults. He is an active member of ASCO and ASTRO and is currently serving as a member of the ASTRO Congressional Relations Subcommittee and a member of the ARRO Communications Subcommittee.
Download my CV .
Interests
- Health and Public Policy
- Achieving Equity in Cancer Outcomes
- Radiation Oncology
- Quasi-experimental methods
- Statistical inference
Education
Residency, Radiation Oncology, 2025
Washington University in St. Louis
MD, 2020
Saint Louis University
MS in Statistics, 2016
Brigham Young University
BS in Statistics, 2016
Brigham Young University
Featured Publications
(2023).
Changes in cancer mortality after Medicaid expansion and the role of stage at diagnosis.
JNCI: Journal of the National Cancer Institute.
(2023).
The association of Medicaid expansion and pediatric cancer overall survival.
JNCI: Journal of the National Cancer Institute.
(2022).
Association of state medicaid expansion status with rates of suicide among US adults.
JAMA network open.
(2022).
Human papillomavirus vaccination and trends in cervical cancer incidence and mortality in the US.
JAMA pediatrics.
(2022).
Short-term Health Insurance Plans Come Up Short for Patients With Cancer.
JAMA oncology.
(2021).
Early Medicaid expansion and cancer mortality.
JNCI: Journal of the National Cancer Institute.
(2020).
Association of Medicaid expansion with insurance coverage among children with cancer.
JAMA pediatrics.
Select Talks
Publications
Quickly discover relevant content by filtering publications.
(2023).
Changes in cancer mortality after Medicaid expansion and the role of stage at diagnosis.
JNCI: Journal of the National Cancer Institute.
(2023).
Facility patient volume and survival among individuals diagnosed with malignant central nervous system tumors.
Journal of Neuro-Oncology.
(2023).
Insurance Coverage and Forgoing Medical Appointments Because of Cost Among Cancer Survivors After 2016.
JCO Oncology Practice.
(2023).
Medicaid expansion is associated with increased 1-year survival for primary malignant brain tumors.
Neuro-Oncology Advances.
(2023).
Racial and ethnic disparities in coexisting cancer and COVID-19 mortality.
Journal of General Internal Medicine.
(2023).
The association of Medicaid expansion and pediatric cancer overall survival.
JNCI: Journal of the National Cancer Institute.
(2022).
Emotional distress among survivors of Adolescent and Young Adult cancer or adult cancer.
Annals of epidemiology.
(2022).
Association of state medicaid expansion status with rates of suicide among US adults.
JAMA network open.
(2022).
Differential Outcomes Among Survivors of Head and Neck Cancer Belonging to Racial and Ethnic Minority Groups.
JAMA Otolaryngology–Head & Neck Surgery.
(2022).
Association of Changes in Medicaid Dental Benefits With Localized Diagnosis of Oral Cavity Cancer.
JAMA oncology.
(2022).
Human papillomavirus vaccination and trends in cervical cancer incidence and mortality in the US.
JAMA pediatrics.
(2022).
Human papillomavirus vaccine uptake among teens before and during the COVID-19 pandemic in the United States.
Human Vaccines & Immunotherapeutics.
(2022).
Short-term Health Insurance Plans Come Up Short for Patients With Cancer.
JAMA oncology.
(2022).
The Affordable Care Act and suicide incidence among adults with cancer.
Journal of Cancer Survivorship.
(2021).
Associations between geographic residence and US adolescent and young adult cancer stage and survival.
Cancer.
(2021).
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis.
Clinical and translational radiation oncology.
(2021).
Early Medicaid expansion and cancer mortality.
JNCI: Journal of the National Cancer Institute.
(2021).
Residential distance from the reporting hospital and survival among adolescents, and young adults diagnosed with CNS tumors.
Journal of Neuro-Oncology.
(2021).
Incidence and risk of suicide among patients with head and neck cancer in rural, urban, and metropolitan areas.
JAMA Otolaryngology–Head & Neck Surgery.
(2020).
Associations between race/ethnicity and US childhood and adolescent cancer survival by treatment amenability.
JAMA pediatrics.
(2020).
Associations of early Medicaid expansion with insurance status and stage at diagnosis among cancer patients receiving radiation therapy.
Practical Radiation Oncology.
(2020).
Change in stage of presentation of head and neck cancer in the United States before and after the affordable care act.
Cancer Epidemiology.
(2020).
Impact of the patient protection and Affordable Care Act on cost-related medication underuse in nonelderly adult cancer survivors.
Cancer.
(2020).
State Medicaid expansion status, insurance coverage and stage at diagnosis in head and neck cancer patients.
Oral Oncology.
(2020).
Association of Medicaid expansion with insurance coverage among children with cancer.
JAMA pediatrics.
(2019).
Variability of retail pricing of generic urologic medications in a major US metropolitan area.
Urology.
(2019).
Impacts of the Affordable Care Act dependent coverage provision on young adults with cancer.
American Journal of Preventive Medicine.
(2019).
Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
Radiotherapy and Oncology.
(2019).
Socioeconomic and demographic variation in insurance coverage among patients with head and neck cancer after the Affordable Care Act.
JAMA Otolaryngology–Head & Neck Surgery.
(2019).
Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer.
Journal of contemporary brachytherapy.
(2019).
Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience.
Journal of Contemporary Brachytherapy.
(2018).
Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of care.
Cancer medicine.
(2018).
Outcomes of renal salvage for penetrating renal trauma: a single institution experience..
The Canadian Journal of Urology.
(2017).
Discovery and confirmation of diagnostic serum lipid biomarkers for Alzheimer’s disease using direct infusion mass spectrometry.
Journal of Alzheimer’s Disease.
(2016).
Global “omics” evaluation of human placental responses to preeclamptic conditions.
American Journal of Obstetrics and Gynecology.
(2016).
Survival analysis.
Forensic Epidemiology.
Training
Resident, Radiation Oncology
Washington University / Barnes Jewish Hospital
Intern, Internal Medicine
St. Luke’s Hospital
Awards and Recognition
Merit Award
ASCO Annual Meeting
Travel Award
Merit Award
ASCO Quality Care Symposium
Special Merit Award
Allen S. Lichter, MD, Endowed Merit Award
Technical Skills
R
Statistics
Contact
- justinbarnes AT wustl DOT edu
- 314 265 1832
- 4921 Parkview Place, Lower Level, St. Louis, MO 63110
- DM Me